Clinical Trials for TargetRx

Explore 8 clinical trials worldwide

Showing 1-8 of 8 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: TargetRx

Clinical Trials (8)

NCT06453902
TGRX-678 Chinese Phase II in Chronic Myelogenous Leukemia (CML) Patients
PHASE2Recruiting
40 participants
Started: Jul 15, 2024 · Completed: Apr 30, 2028
2 conditions11 sponsors1 location
NCT06484816
TGRX-1942 Chinese Phase I for Advanced Solid Tumor And/or Relapsed/Refractory Hematologic Malignancies
PHASE1Recruiting
90 participants
Started: Jul 8, 2024 · Completed: Jun 30, 2027
3 conditions2 sponsors1 location
NCT06088888
TGRX-678 US Phase I for Subjects with Refractory or Advanced Chronic Myelogenous Leukemia
PHASE1Recruiting
90 participants
Started: Jul 2, 2024 · Completed: Jun 30, 2027
1 condition2 sponsors2 locations
NCT06206174
TGRX-814 Chinese Phase I/II in Patients With Hematological Malignancies
PHASE1/PHASE2Recruiting
30 participants
Started: Mar 6, 2024 · Completed: Feb 28, 2029
5 conditions2 sponsors1 location
NCT06082635
TGRX-326 Chinese Phase III for Advanced Non-small Cell Lung Cancer (NSCLC)
PHASE3Active, not recruiting
321 participants
Started: Dec 14, 2023 · Completed: Nov 30, 2028
1 condition2 sponsors1 location
NCT05955391
TGRX-326 Chinese Phase II for Advanced Non-small Cell Lung Cancer (NSCLC)
PHASE2Active, not recruiting
164 participants
Started: Jan 18, 2023 · Completed: Dec 31, 2025
1 condition36 sponsors1 location
NCT05441956
TGRX-326 Chinese Phase I for Advanced Non-small Cell Lung Cancer (NSCLC)
PHASE1Active, not recruiting
198 participants
Started: Apr 23, 2021 · Completed: Oct 31, 2025
1 condition2 sponsors1 location
NCT05434312
TGRX-678 Chinese Phase I in Chronic Myelogenous Leukemia (CML) Patients
PHASE1Active, not recruiting
90 participants
Started: Mar 29, 2021 · Completed: Sep 30, 2026
1 condition2 sponsors1 location